Cited by 253Hormonal and reproductive studiesProstate Cancer Treatment and ResearchEstrogen and related hormone effects

The DOI matches its Crossref record; 118 of the 119 references it cites were found in a registry or an index.

Development of selective androgen receptor modulators (SARMs)

Open access

Narayanan, Ramesh, Coss, Christopher C., Dalton, James T.·2018·Molecular and Cellular Endocrinology

DOI 10.1016/j.mce.2017.06.013PMC PMC5896569

Open this paper in CoChat — free account

Abstract

The Androgen Receptor (AR), a member of the steroid hormone receptor family, plays important roles in the physiology and pathology of diverse tissues. AR ligands, which include circulating testosterone and locally synthesized dihydrotestosterone, bind to and activate the AR to elicit their effects. Ubiquitous expression of the AR, metabolism and cross reactivity with other receptors limit broad therapeutic utilization of steroidal androgens. However, the discovery of selective androgen receptor modulators (SARMs) and other tissue-selective nuclear hormone receptor modulators that activate their cognate receptors in a tissue-selective manner provides an opportunity to promote the beneficial effects of androgens and other hormones in target tissues with greatly reduced unwanted side-effects. In the last two decades, significant resources have been dedicated to the discovery and biological characterization of SARMs in an effort to harness the untapped potential of the AR. SARMs have been proposed as treatments of choice for various diseases, including muscle-wasting, breast cancer, and osteoporosis. This review provides insight into the evolution of SARMs from proof-of-concept agents to the cusp of therapeutic use in less than two decades, while covering contemporary views of their mechanisms of action and therapeutic benefits.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.mce.2017.06.013

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,394
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M., & O’Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,887
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,759
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Population frequencies of inherited neuromuscular diseases—A world survey
Emery, A. E. H. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90039-u · Cited by 1,451
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling
Hall, J. M., Couse, J. F., & Korach, K. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100029200 · Cited by 1,202
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O’Brien, C. A., Bodenner, D., Li, H., Han, K., Gregorio, G. B. D., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,163
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Molecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors
Chang, C. S., Kokontis, J. M., & Liao, S. (1988) · Science · doi:10.1126/science.3353726 · Cited by 891
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity
Kousteni, S. (2001) · Cell · doi:10.1016/s0092-8674(02)08100-x · Cited by 757
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Fang, S., Suh, J. M., Reilly, S. M., Yu, E., Osborn, O., Lackey, D., Yoshihara, E., Perino, A., Jacinto, S., Lukasheva, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3760 · Cited by 738
Formation of the Androgen Receptor Transcription Complex
Shang, Y., Myers, M., & Brown, M. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 673
Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-Hydroxytamoxifen
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.6.0009 · Cited by 665
Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
Temel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00558-6 · Cited by 639
Transcriptional activation and nuclear targeting signals of the human androgen receptor.
Simental, J. A., Sar, M., Lane, M. V., French, F. S., & Wilson, E. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52466-2 · Cited by 631
The Human Androgen Receptor: Complementary Deoxyribonucleic Acid Cloning, Sequence Analysis and Gene Expression in Prostate
Lubahn, D. B., JOSEPH, D. R., Sar, M., Tan, J.-A., Higgs, H. N., Larson, R. E., French, F. S., & Wilson, E. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1265 · Cited by 570
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
Kedar, R. P., Bourne, T., Collins, W. P., Campbell, S. C., Powles, T. J., Ashley, S., & Cosgrove, D. O. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92466-x · Cited by 529
Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523 · cited 1×
“4 leads to a significant loss in AR’s transcriptional c pacity (29,31-33).”
Eteplirsen in the treatment of Duchenne muscular dystrophy
Lim, K. R. Q., Maruyama, R., & Yokota, T. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s97635 · Cited by 496
The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Activation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth, L. V., & Weigel, N. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19900 · Cited by 429
The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1
Bevan, C. L., Hoare, S., Claessens, F., Heery, D. M., & Parker, M. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8383 · Cited by 424
Identification of two transcription activation units in the N-terminal domain of the human androgen receptor
Jenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419
Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Peters, A. A., Buchanan, G., Ricciardelli, C., Bianco‐Miotto, T., Centenera, M. M., Harris, J. M., Jindal, S., Segara, D., Li, J., Moore, N. L. T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0452 · Cited by 406
The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
Dalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., Morton, R. A., & Steiner, M. S. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0034-6 · Cited by 403
Self-citation
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
Dobs, A. S., Boccia, R. V., Croot, C. C., Gabrail, N. Y., Dalton, J. T., Hancock, M. L., Johnston, M. A., & Steiner, M. S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70055-x · Cited by 391
Self-citation
Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors α and β
Chang, C., Norris, J. D., Grøn, H., Paige, L. A., Hamilton, P. T., Kenan, D. J., Fowlkes, D. M., & McDonnell, D. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8226 · Cited by 372
Cooperation of proto‐signals for nuclear accumulation of estrogen and progesterone receptors.
Ylikomi, T. J., Bocquel, M. T., Berry, M., Gronemeyer, H., & Chambon, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05453.x · Cited by 319
Androgen receptor expression in human tissues: an immunohistochemical study.
de Winter, J. A. R., Trapman, J., Vermey, M., Mulder, E., Zegers, N. D., & van der Kwast, T. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.7.1865110 · Cited by 314
A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences.
Zhou, Z. X., Sar, M., Simental, J. A., Lane, M. V., & Wilson, E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36806-0 · Cited by 312
Androgen Receptor in Human Skeletal Muscle and Cultured Muscle Satellite Cells: Up-Regulation by Androgen Treatment
Sinha‐Hikim, I., Taylor, W. E., González-Cadavid, N. F., Zheng, W. D., & Bhasin, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0084 · Cited by 312
Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate
Fujimoto, N., Yeh, S., Kang, H., Inui, S., Chang, H., Mizokami, A., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8316 · Cited by 298
The pathology of the heart in progressive muscular dystrophy: Epimyocardial fibrosis
Frankel, K. A., & Rosser, R. J. (1976) · Human Pathology · doi:10.1016/s0046-8177(76)80053-6 · Cited by 287
Estrogen receptors and human disease: an update
Burns, K. A., & Korach, K. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0868-5 · Cited by 287
The Rat Androgen Receptor: Primary Structure, Autoregulation of its Messenger Ribonucleic Acid, and Immunocytochemical Localization of the Receptor Protein
Tan, J.-A., JOSEPH, D. R., Quarmby, V. E., Lubahn, D. B., Sar, M., French, F. S., & Wilson, E. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-12-1276 · Cited by 275
The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
Alen, P., Claessens, F., Verhoeven, G., Rombauts, W., & Peeters, B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6085 · Cited by 268
The biochemistry of aging muscle
Carmeli, E., Coleman, R., & Reznick, A. Z. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00220-0 · Cited by 257
Cellular and molecular mechanisms underlying muscular dystrophy
Rahimov, F., & Kunkel, L. M. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201212142 · Cited by 252
Development of Cardiomyopathy in Female Carriers of Duchenne and Becker Muscular Dystrophies
Politano, L. (1996) · JAMA · doi:10.1001/jama.1996.03530410049032 · Cited by 234
Cloning and Characterization of Human Prostate Coactivator ARA54, a Novel Protein That Associates with the Androgen Receptor
Kang, H., Yeh, S., Fujimoto, N., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8570 · Cited by 230
Discovery of Nonsteroidal Androgens
Dalton, J. T., Mukherjee, A., Zhu, Z., Kirkovsky, L. I., & Miller, D. D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8209 · Cited by 227
Self-citation
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
Lahti, E. I., Blanco, G., Kauppila, A., Apaja-Sarkkinen, M. A., Taskinen, P. J., & Laatikainen, T. K. (1993) · PubMed · Cited by 224
Protective Effects of Estrogen and Selective Estrogen Receptor Modulators in the Brain1
Dhandapani, K. M., & Brann, D. W. (2002) · Biology of Reproduction · doi:10.1095/biolreprod.102.003848 · Cited by 220
Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT*
Liao, G., Chen, L.-Y., Zhang, A., Godavarthy, A., Xia, F., Ghosh, J. C., Li, H., & Chen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206374200 · Cited by 207
Selective Androgen Receptor Modulator Treatment Improves Muscle Strength and Body Composition and Prevents Bone Loss in Orchidectomized Rats
Gao, W., Reiser, P. J., Coss, C. C., Phelps, M. A., Kearbey, J. D., Miller, D. D., & Dalton, J. T. (2005) · Endocrinology · doi:10.1210/en.2005-0572 · Cited by 196
Self-citation
The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators
He, B., Minges, J. T., Lee, L. W., & Wilson, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111975200 · Cited by 194
Endometrial Histopathology in 700 Patients Treated with Tamoxifen for Breast Cancer
Deligdisch, L., Kalir, T., Cohen, C. J., de Latour, M., Bouëdec, G. L., & Penault-Llorca, F. M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5859 · Cited by 186
Steroid hormone transforming aldo–keto reductases and cancer
Penning, T. M., & Byrns, M. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03700.x · Cited by 181
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)
Crawford, J., Prado, C. M. M., Johnston, M. A., Gralla, R. J., Taylor, R. P., Hancock, M. L., & Dalton, J. T. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0522-0 · Cited by 178
Self-citation
Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice.
Mani, S. K., Allen, J. M., Lydon, J. P., Mulac‐Jeričević, B., Blaustein, J. D., DeMayo, F. J., Conneely, O. M., & O’Malley, B. W. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.12.8961281 · Cited by 178
Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486
Liu, Z., Auboeuf, D., Wong, J., Chen, J. D., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122225699 · Cited by 159
Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation
Lutz, L., Cole, L. M., Gupta, M. K., Kwist, K. W., Auchus, R. J., & Hammes, S. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241471598 · Cited by 159
The Age-Related Decline in Resting Energy Expenditure in Humans Is Due to the Loss of Fat-Free Mass and to Alterations in Its Metabolically Active Components
Bosy‐Westphal, A., Eichhorn, C., Kutzner, D., Illner, K., Heller, M., & Müller, M. J. (2003) · Journal of Nutrition · doi:10.1093/jn/133.7.2356 · Cited by 146
Androgens suppress osteoclast formation induced by RANKL and macrophage colony-stimulating factor.
Huber, D. M., Bendixen, A. C., Pathrose, P., Srivastava, S., Dienger, K. M., Shevde, N. K., & Pike, J. W. (2001) · Endocrinology · doi:10.1210/endo.142.9.8402 · Cited by 141
An Orally Active Selective Androgen Receptor Modulator Is Efficacious on Bone, Muscle, and Sex Function with Reduced Impact on Prostate
Miner, J. N., Chang, W. Y., Chapman, M. S., Finn, P. D., Hong, M. H., LÓPEZ, F. J., Marschke, K. B., Rosen, J., Schrader, W. T., Turner, R. T., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0793 · Cited by 136
Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element
Clinckemalie, L., Spans, L., Dubois, V., Laurent, M. R., Helsen, C., Joniau, S., & Claessens, F. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1098 · Cited by 136
Steroid 5alpha-reductase deficiency in man. An inherited form of male pseudohermaphroditism.
Imperato‐McGinley, J., Guerrero, L., Gautier, T., Jl, G., & Peterson, R. E. (1975) · PubMed · Cited by 135
Sarcopenia and frailty in geriatric patients: Implications for training and prevention
M�hlberg, W., & Sieber, C. C. (2004) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-004-0203-8 · Cited by 134
Bone Anabolic Effects of S-40503, a Novel Nonsteroidal Selective Androgen Receptor Modulator (SARM), in Rat Models of Osteoporosis
Hanada, K., Furuya, K., Yamamoto, N., Nejishima, H., Ichikawa, K., Nakamura, T., Miyakawa, M., Amano, S., Sumita, Y., & Oguro, N. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1563 · Cited by 122
Nongenomic Androgen Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in MC3T3-E1 Osteoblasts
Kang, H., Cho, C.-L., Huang, K.-L., Wang, J.-C., Hu, Y., Lin, H., Chang, C., & Huang, K. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040306 · Cited by 114
Selective Modulation of Genomic and Nongenomic Androgen Responses by Androgen Receptor Ligands
Lutz, L. B., Jamnongjit, M., Yang, W., Jahani, D., Gill, A., & Hammes, S. R. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0032 · Cited by 112
Ligand-independent Androgen Receptor Activity Is Activation Function-2-independent and Resistant to Antiandrogens in Androgen Refractory Prostate Cancer Cells
Dehm, S. M., & Tindall, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605002200 · Cited by 111
Selective Androgen Receptor Modulator (SARM) Treatment Prevents Bone Loss and Reduces Body Fat in Ovariectomized Rats
Kearbey, J. D., Gao, W., Narayanan, R., Fisher, S. J., Wu, D., Miller, D. D., & Dalton, J. T. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9152-9 · Cited by 110
Self-citation
New insights into activation of the steroid hormone receptor superfamily
Power, R. F., Conneely, O. M., & O’Malley, B. W. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90099-r · Cited by 108
Key Structural Features of Nonsteroidal Ligands for Binding and Activation of the Androgen Receptor
Yin, D., He, Y., Perera, M. A., Hong, S., Marhefka, C. A., Stourman, N. V., Kirkovsky, L. I., Miller, D. D., & Dalton, J. T. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.211 · Cited by 106
Self-citation
Request for regulatory guidance for cancer cachexia intervention trials
Fearon, K. C. H., Argilés, J. M. A., Baracos, V., Bernabei, R., Coats, A., Crawford, J., Deutz, N. E. P., Doehner, W., Evans, W. J., Ferrucci, L., et al. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12083 · Cited by 105
G Protein βγ Subunits Inhibit Nongenomic Progesterone-induced Signaling and Maturation in Xenopus laevis Oocytes
Lutz, L. B., Kim, B., Jahani, D., & Hammes, S. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006757200 · Cited by 94
Steroid receptor phosphorylation: Assigning function to site‐specific phosphorylation
Ward, R. D., & Weigel, N. L. (2009) · BioFactors · doi:10.1002/biof.66 · Cited by 92
Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men
Blouin, K., Richard, C., Brochu, G., Hould, F.-S., Lebel, S., Marceau, S., Biron, S., Luu-The, V., & Tchernof, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06365 · Cited by 90
Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy
Chu, M. P., Lieffers, J. R. L., Ghosh, S., Belch, A. R., Chua, N. S., Fontaine, A., Sangha, R. S., Turner, R. A., Baracos, V. E., & Sawyer, M. B. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12161 · Cited by 86
Loss of muscle mass in the end of life in patients with advanced cancer
Wallengren, O., Iresjö, B., Lundholm, K., & Bosaeus, I. G. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2332-y · Cited by 83
Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells
Baek, S. H., Ohgi, K. A., Nelson, C. A., Welsbie, D. S., Chen, C., Sawyers, C. L., Rose, D. W., & Rosenfeld, M. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510842103 · Cited by 81
Evaluation of Ligand-Dependent Changes in AR Structure Using Peptide Probes
Chang, C., & McDonnell, D. P. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0818 · Cited by 80
Androgenic pathway in triple negative invasive ductal tumors: Its correlation with tumor cell proliferation
McNamara, K. M., Yoda, T., Miki, Y., Chanplakorn, N., Wongwaisayawan, S., Incharoen, P., Kongdan, Y., Wang, L., Takagi, K., Takagi, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12121 · Cited by 79
New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone
Edwards, J. P., West, S. J., Pooley, C. L. F., Marschke, K. B., Farmer, L. J., & Jones, T. K. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00107-3 · Cited by 79
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
Madeira, M., Mattar, A. P. L., Logullo, Â. F., Soares, F. A., & Gebrim, L. H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-425 · Cited by 79
Androgen receptor–cofactor interactions as targets for new drug discovery
Chang, C., & McDonnell, D. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.002 · Cited by 78
Steroidal Androgens and Nonsteroidal, Tissue-Selective Androgen Receptor Modulator, S-22, Regulate Androgen Receptor Function through Distinct Genomic and Nongenomic Signaling Pathways
Narayanan, R., Coss, C. C., Yepuru, M., Kearbey, J. D., Miller, D. D., & Dalton, J. T. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0160 · Cited by 78
Self-citation
Enobosarm (GTx-024, S-22): A Potential Treatment for Cachexia
Srinath, R., & Dobs, A. S. (2014) · Future Oncology · doi:10.2217/fon.13.273 · Cited by 75
Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators.
Kazmin, D., Prytkova, T., Cook, C., Wolfinger, R., Chu, T.-M., Beratan, D., Norris, J., Chang, C.-Y., & McDonnell, D. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0309 · Cited by 72
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
Narayanan, R., & Dalton, J. T. (2016) · Cancers · doi:10.3390/cancers8120108 · Cited by 68
Self-citation
Effects of a Novel Selective Androgen Receptor Modulator on Dexamethasone-Induced and Hypogonadism-Induced Muscle Atrophy
Jones, A. J., Hwang, D., Narayanan, R., Miller, D. D., & Dalton, J. T. (2010) · Endocrinology · doi:10.1210/en.2010-0150 · Cited by 67
Self-citation
Nuclear receptor modulation – Role of coregulators in selective estrogen receptor modulator (SERM) actions
Feng, Q. F., & O’Malley, B. W. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.008 · Cited by 65
Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic Anabolism Versus Reproductive Physiology
Schmidt, A., Kimmel, D. B., Bai, C., Scafonas, A., Rutledge, S., Vogel, R. L., McElwee-Witmer, S., Chen, F., Nantermet, P. V., Kasparcova, V., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.099002 · Cited by 64
Enobosarm (GTx-024) Modulates Adult Skeletal Muscle Mass Independently of the Androgen Receptor in the Satellite Cell Lineage
Dubois, V., Simitsidellis, I., Laurent, M. R., Jardí, F., Saunders, P. T. K., Vanderschueren, D., & Claessens, F. (2015) · Endocrinology · doi:10.1210/en.2015-1479 · Cited by 61
GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy
Cozzoli, A., Capogrosso, R. F., Sblendorio, V. T., Dinardo, M. M., Jagerschmidt, C., Namour, F., Camerino, G. M., & Luca, A. D. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.003 · Cited by 56
A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer
Schwartzberg, L. S., Yardley, D. A., ELIAS, A. D., Patel, M. R., LoRusso, P. M., Burris, H. A., Gucalp, A., Peterson, A., Blaney, M. E., Steinberg, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2339 · Cited by 55
4-Alkyl- and 3,4-dialkyl-1,2,3,4,-tetrahydro-8-pyridono[5,6-g]quinolines: Potent, nonsteroidal androgen receptor agonists
Higuchi, R. I., Edwards, J. P., Caferro, T. R., Ringgenberg, J. D., Kong, J. W., Hamann, L. G., Arienti, K. L., Marschke, K. B., Davis, R. L., Farmer, L. J., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00186-9 · Cited by 52
Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men with Late-Onset Hypogonadism
Permpongkosol, S., Khupulsup, K., Leelaphiwat, S., Pavavattananusorn, S., Thongpradit, S., & Petchthong, T. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.06.003 · Cited by 51
Functional Characterization of the Native NH2-Terminal Transactivation Domain of the Human Androgen Receptor: Binding Kinetics for Interactions with TFIIF and SRC-1a
Lavery, D. N., & McEwan, I. J. (2008) · Biochemistry · doi:10.1021/bi702220p · Cited by 50
Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs
Holterhus, P., Piefke, S., & Hiort, O. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00220-0 · Cited by 49
Prevention and Treatment of Osteoporosis in Women With Breast Cancer
Mincey, B. A., Moraghan, T. J., & Perez, E. A. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.8.821 · Cited by 46
Clomiphene in the treatment of oligomenorrhea and amenorrhea
Charles, D., Barr, W., Bell, E. T., Brown, J. B., Fotherby, K., & LORAINE, J. A. (1963) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)35246-2 · Cited by 45
Ockham's Razor and Selective Androgen Receptor Modulators (SARMs): Are We Overlooking the Role of 5 -Reductase?
Gao, W., & Dalton, J. T. (2007) · Molecular Interventions · doi:10.1124/mi.7.1.3 · Cited by 44
Self-citation
Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer
Liu, J., Motoyama, S., Sato, Y., Wakita, A., Kawakita, Y., Saito, H., & Minamiya, Y. (2016) · Anticancer Research · doi:10.21873/anticanres.11278 · Cited by 39
Testosterone attenuates p38 MAPK pathway during Leishmania donovani infection of macrophages
Liu, L., Wang, L., Zhao, Y., Wang, Y., Wang, Z., & Qiao, Z. (2006) · Parasitology Research · doi:10.1007/s00436-006-0168-1 · Cited by 39
The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response
Verrijdt, G., Tanner, T., Moehren, U., Callewaert, L., Haelens, A., & Claessens, F. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341089 · Cited by 39
Effects of Dihydrotestosterone on Bone Biochemical Markers in Sham and Oophorectomized Rats
Mason, R. A., & Morris, H. A. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1431 · Cited by 37
Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidates
Mohler, M. L., Nair, V. A., Hwang, D., Rakov, I. M., Patil, R., & Miller, D. D. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.11.1565 · Cited by 37
The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects
Fujimoto, J., Nishigaki, M., Hori, M., Ichigo, S., Itoh, T., & Tamaya, T. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90020-5 · Cited by 36
Antidiabetic Activity of Passive Nonsteroidal Glucocorticoid Receptor Modulators
Link, J. T., Sorensen, B. K., Patel, J. R., Grynfarb, M., Goos‐Nilsson, A., Wang, J., Fung, S., Wilcox, D. M., Zinker, B. A., Nguyen, P., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050205o · Cited by 35
Org 214007-0: A Novel Non-Steroidal Selective Glucocorticoid Receptor Modulator with Full Anti-Inflammatory Properties and Improved Therapeutic Index
van Lierop, M.-J. C., Alkema, W. B. L., Laskewitz, A. J., Dijkema, R., van der Maaden, H. M., Smit, M. J., Plate, R., Conti, P. G. M., Jans, C. G. J. M., Timmers, C. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048385 · Cited by 35
Tissue Selective Androgen Receptor Modulators (SARMs) Increase Pelvic Floor Muscle Mass in Ovariectomized Mice
Ponnusamy, S., Sullivan, R. D., Thiyagarajan, T., Heather, T., Getzenberg, R. H., & Narayanan, R. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25751 · Cited by 35
Self-citation
Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer
Coss, C. C., Jones, A. J., & Dalton, J. T. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.010 · Cited by 34
Self-citation
Identification of androgen-selective androgen-response elements in the human aquaporin-5 and Rad9 genes
Moehren, U., Denayer, S., Podvinec, M., Verrijdt, G., & Claessens, F. (2008) · Biochemical Journal · doi:10.1042/bj20071352 · Cited by 33
Discovery and Mechanistic Characterization of a Novel Selective Nuclear Androgen Receptor Exporter for the Treatment of Prostate Cancer
Narayanan, R., Yepuru, M., Szafran, A. T., Szwarc, M. M., Bohl, C. E., Young, N. L., Miller, D. D., Mancini, M. A., & Dalton, J. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3206 · Cited by 24
Self-citation
Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined?
Traish, A. M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00174.2016 · Cited by 23
CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton
Tabata, Y., Iizuka, Y., Shinei, R., Kurihara, K., Okonogi, T., Hoshiko, S., & Kurata, Y. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02958-8 · Cited by 15
Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication
Sultana, A., Idress, R., Naqvi, Z. A., Azam, I., Khan, S. M., Siddiqui, A. A., & Lalani, E. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.04.004 · Cited by 15
Metabolism of androstenedione and testosterone in human fetal brain
Schindler, A. E. (1975) · Progress in brain research · doi:10.1016/s0079-6123(08)63689-4 · Cited by 7
Testosterone influenced the expression of Notch1, Notch2 and Jagged1 induced by lipopolysaccharide in macrophages
Guo, D., Zhang, H., Liu, L., Wang, L., Cheng, Y., & Qiao, Z. (2004) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2004.07.002 · Cited by 7
Using Intrinsic Fluorescence Emission Spectroscopy to Study Steroid Receptor and Coactivator Protein Conformation Dynamics
Watt, K., & McEwan, I. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-575-0_12 · Cited by 3

Research works printed but not linked: 1

Ponnusamy, 2016, Tissue selective androgen receptor modulators (SARMs) increase pelvic floor muscle mass in ovariectomized mice, J. Cell Biochem.

Sorted by citations

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Mesinovic, J., Zengin, A., de Courten, B. V., Ebeling, P. R., & Scott, D. S. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s186600 · Cited by 603
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Zeng, S., Huang, W., Zheng, X., Cheng, L., Zhang, Z., Wang, J., & Shen, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112981 · Cited by 264
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Hickey, T. E., Selth, L. A., Chia, K. M., Laven‐Law, G., Milioli, H. H., Roden, D. L., Jindal, S., Hui, M. N., Finlay-Schultz, J., Ebrahimie, E., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01168-7 · Cited by 261
Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
Vignera, S. L., Cannarella, R., Condorelli, R. A., Torre, F., Aversa, A., & Calogero, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082948 · Cited by 234
Osteosarcopenia: A case of geroscience
Kirk, B., Saedi, A. A., & Duque, G. (2019) · Aging Medicine · doi:10.1002/agm2.12080 · Cited by 178

See all 253

Authors: Narayanan, R., Coss, C. C., & Dalton, J. T.
Affiliations: University of Tennessee Health Science Center (US)
The Ohio State University (US)
University of Michigan (US)
Corresponding author: Dalton, James T.
ORCID: Narayanan, Ramesh
Coss, Christopher C.
Dalton, James T.
Venue: Molecular and Cellular Endocrinology
Publisher: Elsevier BV
Published: 2018-04
Volume: 465
Pages: 134-142
ISSN: 0303-7207 (ISSN-L)
DOI: 10.1016/j.mce.2017.06.013
PMC: PMC5896569
OpenAlex: W2625829876
Cited by: 251
References: 119
Citations by year: 2026: 17 · 2025: 22 · 2024: 19 · 2023: 38 · 2022: 42 · 2021: 37 · 2020: 27 · 2019: 24 · 2018: 21
FWCI: 3.00
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Molecular and Cellular Endocrinology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (K12CA133250)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: selective androgen receptor modulators, androgen receptor, testosterone, dihydrotestosterone, muscle atrophy, breast cancer, osteoporosis, mechanism of action, drug development
MeSH terms: Androgens, Animals, Humans, Models, Biological, Organ Specificity, Receptors, Androgen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development of selective androgen receptor modulators (SARMs)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks